925200-31-3 Usage
Uses
Used in Pharmaceutical Research:
1-(2-Chloro-6-fluoro-benzyl)-5-methyl-1H-pyrazol-3-ylamine is used as a compound in pharmaceutical research for its potential biological activity. 1-(2-CHLORO-6-FLUORO-BENZYL)-5-METHYL-1 H-PYRAZOL-3-YLAMINE's unique structure suggests that it may possess a variety of pharmacological properties, making it a candidate for further study and development.
Used in Drug Development:
In the field of drug development, 1-(2-Chloro-6-fluoro-benzyl)-5-methyl-1H-pyrazol-3-ylamine is utilized as a starting material or intermediate for the synthesis of new drugs. Its chemical structure allows for modifications and optimizations to enhance its therapeutic effects and selectivity, potentially leading to the creation of novel medications.
Used in Chemical Synthesis:
1-(2-Chloro-6-fluoro-benzyl)-5-methyl-1H-pyrazol-3-ylamine serves as a key intermediate in the synthesis of various chemical products. Its versatile structure allows for further functionalization and incorporation into more complex molecules, which can be applied in different industries, such as materials science, agrochemicals, and specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 925200-31-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,5,2,0 and 0 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 925200-31:
(8*9)+(7*2)+(6*5)+(5*2)+(4*0)+(3*0)+(2*3)+(1*1)=133
133 % 10 = 3
So 925200-31-3 is a valid CAS Registry Number.
925200-31-3Relevant academic research and scientific papers
(PYRAZOL-3-YL)-1,3,4-THIADIAZOL-2-AMINE AND (PYRAZOL-3-YL)-1,3,4-THIAZOL-2-AMINE COMPOUNDS
-
Page/Page column 23, (2012/04/23)
A compound of Formula (I) wherein: either X is N and Y is CR5 or X is C and Y is S; Z is selected from N and CH; R1 is selected from H and Me; R2 is selected from H, OH, OMe and Me; each R3 is independently selected from C1-3alkyl, F, Cl, Br, CF3 and NH2; R4 is selected from Me, CF3, NO2 and CHF2; R5 is selected from H, Me and CHF2; R6 is selected from H and Me; and p is 0-3, compositions containing them, their use in therapy, for example in the treatment of tuberculosis, and methods for the preparation of such compounds, are provided.
